Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Our 2024 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action

Resources

Please use the filters below to refine your search

2486 results found

A close-up photo shows pills in the hand of an MDR TB patient taking his Direct Observation Treatment Short Course (DOTs) medication at the Nhlangano TB Ward supported by MSF.

Issue brief |

31 March 1999

Globalization and medications : a new constraint for developing countries

Tags Intellectual property and trade

Events |

27 February 1999

AIDS and essential medicines and compulsory licensing

Tags HIV/AIDS HIV/AIDS antiretroviral medicines compulsory licence

Research article |

26 January 1999

Access to essential drugs in poor countries: a lost battle?

Tags Research and development neglected diseases

Mr Mandela at a meeting with people who are on the ARV treatment during his visit to Siyaphila la HIV Treatment Program hosted by MSF and the Nelson Mandela Foundation. The event was held at the Lusikiki Teacher's Training College. Photograph by Mariella Furrer

20 February 1998

1998: Big Pharma versus Nelson Mandela

Tags Intellectual property and trade TRIPS South Africa

Feature story |

21 December 2017

Global Fund Board Commits to New Funding Round

Tags HIV/AIDS

Feature story |

21 December 2017

Alexis' Story: Battling Endemic Malnutrition in Burkina Faso

Tags Malnutrition Burkina Faso